Skip to main content
Premium Trial:

Request an Annual Quote

Genomatix Licenses Software to NCI

NEW YORK, Sept. 20 (GenomeWeb News) - Genomatix Software said today that it has licensed its Genomatix Suite to the National Cancer Institute, allowing for 100 intramural researchers at all of the 21 NIH institutes to have full access to the software analysis tools and database.

 

The tools in GenomatixSuite are designed for analysis of gene regulatory networks and pathways, and also include a database of mammalian promoter DNA sequences, according to Genomatix.

 

Specific terms of the NCI deal were not disclosed.

 

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more